Eli Lilly

Eli Lilly Introduces Mounjaro Single-Dose Vial for Diabetes and Obesity

Sectors

Eli Lilly Introduces Mounjaro Single-Dose Vial for Diabetes and Obesity

Mounjaro® is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

By SMEStreet Edit Desk

Mar 21, 2025 00:44 IST logo

3 Min read

Vineet Gupta, Eli Lilly

Eli Lilly Introduces Ramiven in India for Early Stage Breast Cancer Patients

By SMEStreet Edit Desk

Nov 26, 2022 07:32 IST logo

1 Min read

Luca Visini, Eli Lilly

Eli Lilly Issued Royalty Free Licenses for Baricitinib to Indian Pharma Companies

By SMEStreet Edit Desk

May 13, 2021 08:20 IST logo

2 Min read

US Allows Emergency Use of Eli Lilly's COVID-19 Antibody Treatment

By SMEStreet Edit Desk

Nov 10, 2020 10:50 IST logo

2 Min read